{"entity":{"id":"nct07019779","kind":"trial","name":"Study of CM518D1 in Patients With Advanced Solid Tumors","aka":[],"tldr":"A phase 1/2 trial of CM518D1 in advanced solid tumours, run by Keymed Biosciences Co.Ltd, now recruiting.","summary":"Study of CM518D1 in Patients With Advanced Solid Tumors is a phase 1/2 interventional study registered as NCT07019779 by Keymed Biosciences Co.Ltd, with 434 participants planned, started 2025-06-27 and due to reach its primary completion in 2028-12-31. Interventions recorded: CM518D1.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT07019779","url":"https://clinicaltrials.gov/study/NCT07019779"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["keymed"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT07019779","phase":"1/2","setting":"A Multicenter, Open-Label, Phase I/II Clinical Study to Evaluate CM518D1 in the Treatment of Patients With Advanced Solid Tumors","sponsor":"Keymed Biosciences Co.Ltd","enrolled":434,"outcomes":[]},"route":"/trials/nct07019779/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"company":[{"id":"keymed","kind":"company","name":"Keymed Biosciences (KYM Biosciences)","route":"/companies/keymed/"}]}}